JPWO2022047579A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022047579A5 JPWO2022047579A5 JP2023537444A JP2023537444A JPWO2022047579A5 JP WO2022047579 A5 JPWO2022047579 A5 JP WO2022047579A5 JP 2023537444 A JP2023537444 A JP 2023537444A JP 2023537444 A JP2023537444 A JP 2023537444A JP WO2022047579 A5 JPWO2022047579 A5 JP WO2022047579A5
- Authority
- JP
- Japan
- Prior art keywords
- chemical compound
- atom
- group
- alkyl group
- fluorine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073104P | 2020-09-01 | 2020-09-01 | |
| US63/073,104 | 2020-09-01 | ||
| PCT/CA2021/051209 WO2022047579A1 (en) | 2020-09-01 | 2021-09-01 | Halogenated psilocybin derivatives and methods of using |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539949A JP2023539949A (ja) | 2023-09-20 |
| JP2023539949A5 JP2023539949A5 (https=) | 2024-09-09 |
| JPWO2022047579A5 true JPWO2022047579A5 (https=) | 2024-09-09 |
Family
ID=80492287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537444A Pending JP2023539949A (ja) | 2020-09-01 | 2021-09-01 | ハロゲン化シロシビン誘導体および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11998557B2 (https=) |
| EP (1) | EP4208445A4 (https=) |
| JP (1) | JP2023539949A (https=) |
| KR (1) | KR20230062595A (https=) |
| CN (1) | CN116348106A (https=) |
| AU (1) | AU2021337466A1 (https=) |
| CA (1) | CA3191102A1 (https=) |
| IL (1) | IL301026A (https=) |
| MX (1) | MX2023002557A (https=) |
| WO (1) | WO2022047579A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114787363A (zh) * | 2019-10-01 | 2022-07-22 | 恩派瑞安神经科学公司 | 对真菌进行遗传工程化以调节色胺表达 |
| KR20230124103A (ko) * | 2020-02-18 | 2023-08-24 | 길가메쉬 파마슈티컬스, 인코포레이티드 | 기분 장애 치료에 사용되기 위한 특이적 트립타민 |
| EP4347559A4 (en) * | 2021-06-02 | 2025-04-09 | Saint Joseph's University | FLUORINATED TRYPTAMINE COMPOUNDS, RELATED ANALOGUES AND METHODS USING THEM |
| EP4457336A4 (en) | 2021-12-31 | 2026-01-14 | Empyrean Neuroscience Inc | ORGANISMS GENETICALLY MODIFIED TO PRODUCE PSYCHOTROPIC ALKALOIDS |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| WO2024178504A1 (en) * | 2023-02-27 | 2024-09-06 | Enveric Biosciences Canada Inc. | Tri-halo-alkoxy-substituted tryptamine derivatives and methods of using |
| US12157722B1 (en) | 2023-08-03 | 2024-12-03 | Gilgamesh Pharmaceuticals, Inc. | Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| US12129234B1 (en) | 2023-08-03 | 2024-10-29 | Gilgamesh Pharmaceuticals, Inc. | Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| CN121866243A (zh) * | 2023-09-07 | 2026-04-14 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 致幻化合物、其制备方法及其用途 |
| GB202315025D0 (en) * | 2023-09-29 | 2023-11-15 | Psylink Uab | Production and medical use of psilocybin and related compounds |
| WO2025073360A1 (en) | 2023-10-04 | 2025-04-10 | Enzyan Biocatalysis Gmbh | Biocatalytic cascade for the production of tryptamine derivatives |
| WO2025189271A1 (en) * | 2024-03-15 | 2025-09-18 | Enveric Biosciences Canada Inc. | N-heterocycle substituted tryptamine derivatives and methods of using |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1255199B (it) * | 1992-07-01 | 1995-10-20 | Franco Fraschini | Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani |
| US5688807A (en) * | 1994-03-11 | 1997-11-18 | Eli Lilly And Company | Method for treating 5HT2B receptor related conditions |
| CN1148340A (zh) * | 1994-03-11 | 1997-04-23 | 伊莱利利公司 | 治疗与5htzb受体有关病症的方法 |
| CA2393910A1 (en) * | 1999-12-15 | 2001-06-21 | Syngenta Participations Ag | Compositions and methods for halogenation reactions |
| AU2003249584B9 (en) | 2002-06-21 | 2008-05-15 | Suven Life Sciences Limited | Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| WO2004085392A1 (en) * | 2003-03-25 | 2004-10-07 | Faust Pharmaceuticals | Melatonin derivatives and their use for treating neurological dysfunctions |
| US20080171779A1 (en) * | 2007-01-16 | 2008-07-17 | Solvay Pharmaceuticals B.V. | Use of 5-ht6 antagonists to prevent relapse into addiction |
| US20090093513A1 (en) * | 2007-10-09 | 2009-04-09 | Hamann Mark T | Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter |
| CN104276993B (zh) * | 2013-07-12 | 2019-03-15 | 广东东阳光药业有限公司 | 吲哚衍生物及其在药物上的应用 |
| WO2018064465A1 (en) * | 2016-09-29 | 2018-04-05 | The Regents Of The University Of California | Compounds for increasing neural plasticity |
| WO2018106907A1 (en) * | 2016-12-08 | 2018-06-14 | Novatarg, Inc. | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therary |
| MA50786A (fr) | 2017-10-26 | 2022-04-27 | Blumentech S L | Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques |
| JP7093961B2 (ja) * | 2018-02-13 | 2022-07-01 | 国立大学法人金沢大学 | ストレス低減薬剤 |
| CN120555529A (zh) * | 2018-03-08 | 2025-08-29 | 指南针探路者有限公司 | 生产色胺的方法 |
| FI129102B (en) * | 2018-03-19 | 2021-07-15 | Teknologian Tutkimuskeskus Vtt Oy | Heterological production of psilosybin |
| CN119954801A (zh) * | 2019-07-17 | 2025-05-09 | 阿尔维纳斯运营股份有限公司 | Tau蛋白靶向化合物及相关使用方法 |
| CA3160793A1 (en) * | 2019-12-04 | 2021-06-10 | Neonmind Biosciences Inc. | Use of psilocin, psilocybin or analogs thereof in weight loss, treatment of obesity and compulsive eating disorder |
| KR20230124103A (ko) * | 2020-02-18 | 2023-08-24 | 길가메쉬 파마슈티컬스, 인코포레이티드 | 기분 장애 치료에 사용되기 위한 특이적 트립타민 |
| JP2023540329A (ja) | 2020-09-04 | 2023-09-22 | ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド | アゼチジニルトリプタミン及び精神障害を処置する方法 |
-
2021
- 2021-09-01 MX MX2023002557A patent/MX2023002557A/es unknown
- 2021-09-01 JP JP2023537444A patent/JP2023539949A/ja active Pending
- 2021-09-01 EP EP21863150.5A patent/EP4208445A4/en active Pending
- 2021-09-01 AU AU2021337466A patent/AU2021337466A1/en active Pending
- 2021-09-01 IL IL301026A patent/IL301026A/en unknown
- 2021-09-01 CA CA3191102A patent/CA3191102A1/en active Pending
- 2021-09-01 KR KR1020237010996A patent/KR20230062595A/ko active Pending
- 2021-09-01 CN CN202180067808.XA patent/CN116348106A/zh active Pending
- 2021-09-01 WO PCT/CA2021/051209 patent/WO2022047579A1/en not_active Ceased
-
2022
- 2022-09-06 US US17/903,080 patent/US11998557B2/en active Active
-
2024
- 2024-05-06 US US18/655,793 patent/US12138276B2/en active Active
- 2024-10-08 US US18/909,368 patent/US20250057861A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022047579A5 (https=) | ||
| US4386081A (en) | Phosphonoformic acid esters and pharmaceutical compositions containing same | |
| JPH0259833B2 (https=) | ||
| CA2409613A1 (en) | Methods and compositions for treating hepatitis c virus | |
| JPWO2022016070A5 (https=) | ||
| RU2005132168A (ru) | Биарилзамещенные триазолы как блокаторы натриевых каналов | |
| RU2000132188A (ru) | Производные эпотилонов, их синтез и применение | |
| JPWO2020123827A5 (https=) | ||
| CA2736039A1 (en) | Novel prostaglandin i2 derivative | |
| JPH05509307A (ja) | プリンの抗ウイルス性ホスホノ―アルケン誘導体 | |
| JPWO2022152821A5 (https=) | ||
| RU98100076A (ru) | Применение производных 1,2,4-триазола для получения лекарственного средства для лечения рака | |
| JP2025118775A5 (https=) | ||
| JP2006504673A5 (https=) | ||
| JPWO2022047583A5 (https=) | ||
| JPWO2021097345A5 (https=) | ||
| CN1147765A (zh) | 肺性心病治疗剂 | |
| JPWO2020089025A5 (https=) | ||
| JPWO2022177840A5 (https=) | ||
| JPWO2021163627A5 (https=) | ||
| JPWO2023129956A5 (https=) | ||
| JPWO2023107563A5 (https=) | ||
| CN1589142A (zh) | 三环－[5.2.1.02.6]－癸－9－基－黄原酸酯的纯立体异构体的制备和由其制成的药物 | |
| CZ292531B6 (cs) | Fosfolipidické deriváty fosfonokarboxylových kyselin, jejich použití a léčiva na jejich bázi | |
| JPWO2023143520A5 (https=) |